Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Track-2 (Emerald 3): Chemical Biology Approaches to Drug Discovery

Track-2 (Emerald 3): Chemical Biology Approaches to Drug Discovery Agenda



Co-Located Conference Agendas

Indian Lab Automation | Drug Discovery India 2014 | Drug Metabolism & Discovery ADMET | 


Other Track Agendas

Track-1 (Emerald 2): Synthesis & Screening of Drugs & Phytochemicals | Track-2 (Emerald 3): Chemical Biology Approaches to Drug Discovery | 

Print Agenda

Thursday, 11 September 2014

08:00

Registration

09:15

Inauguration

09:20

Chairman's Welcome and Inaugural Talk

09:30

Renaissance in Pharmacognosy: The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

10:15

Memento Presentation

10:25

Coffee and Networking in Exhibition Area


SESSION 1: Chemical Approaches for Target Identification and Validation

10:55

Jyoti ChattopadhyayaKeynote Presentation

Understanding the Principles for harnessing Key Phosphate Hydrolysis Step in DNA and RNA complexes with Enzymes.
Jyoti Chattopadhyaya, Professor, Uppsala University, Sweden

11:30

A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5)
Harish Pant, Senior Investigator, National Institute of Health, United States of America

12:00

Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session
Maria Costi, Professor, University of Modena and Reggio Emilia, Italy

12:30

Accelrys-BIOVIATechnology Spotlight:
Using Protein Design Tools to Guide Pharmacophore Generation and Screening
Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA


SESSION 2: Achieving Therapeutic Goals through PPIs and Epigenetics

12:45

Krishna BanaudhaKeynote Presentation

Integrative Medicine: A Roadmap of Epigenetic Modulation in Health, Diseases Prevention and Cure
Krishna Banaudha, Associate Professor, The George Washington University, United States of America

13:20

Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India

13:50

Lunch and Networking in Exhibition Area


SESSION 3: Target based Drug Discovery- New Targets & Novel Approaches

14:30

Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells
Umesh Desai, Professor, Virginia Commonwealth University, United States of America

15:00

Agilent TechnologiesTechnology Spotlight:
Maximising Value and Success with Automation
Lesley Schultz, Product Manager, Agilent Technologies

15:15

Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets
Amit Banerjee, Professor, Wayne State University , United States of America

16:15

Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo, Norway

16:45

Molecular Methods that Enable Targeted Therapeutics and Precision Medicine
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc, United States of America

17:15

End of First Day of Conference

17:30

FREE WORKSHOP: RNA Silencing for Drug Discovery- Challenges and Strategies

Friday, 12 September 2014


SESSION 4: Phenotypic Screening and Cell based Assay Methods for Drug Discovery

09:30

Plenary Presentation: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France

10:00

Stem Cell Based Chip Platforms In Drug Discovery
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd., India

10:30

Tecan Trading AGTechnology Spotlight:
Fluent Laboratory Automation Solution for Cell based Assays
Roland Durner, Global Head of LSB Distributors, Tecan Trading AG

10:45

Coffee Break and Networking in Exhibition Area

11:05

Annotating Biological Activities of Drugs, Natural Products and Environmental Toxicants by FACTORIAL Pathway Profiling Assays
Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America

11:35

Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics and Personalized Medicine
John Watson, Director of Marketing, Promega Corporation, United States of America


SESSION 5: Rare Diseases, Orphan Drugs and Drug Repurposing

12:05

Optimisation of New Trypanosoma brucei Inhibitors
Raphael Rahmani, Research Fellow, Monash University, Australia

12:35

Repositioning of Drugs- Structure-Based Approach Towards Finding New Leads as Antileishmanial Agents
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute, India

13:05

Special Lecture: Natural Products Repurposing for Cancer Therapy
Petr Bartunek, Group Leader, Institute of Molecular Genetics, Czech Republic

13:40

Lunch and Networking in Exhibition Area

14:20

POSTER EVALUATION


SESSION 6: Collaborative and Open Source Drug Discovery

14:40

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

15:10

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

15:40

Crowdsourcing Systems Level Platform for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

16:00

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

16:20

Open Discussion on Open Source Drug Discovery

16:40

Coffee Break and Networking in Exhibition Area

16:55

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

17:30

End of the Conference


Agenda is not currently available
Add to Calendar ▼2014-09-11 00:00:002014-09-12 00:00:00Europe/LondonTrack-2 (Emerald 3): Chemical Biology Approaches to Drug DiscoverySELECTBIOenquiries@selectbiosciences.com